Product
Supplier
Encyclopedia
Inquiry
Cagrilintide-5mg buy - large image1
Cagrilintide-5mg buy - image1

Cagrilintide-5mg

59 Inquiries

Unit Price: Get Latest Price
CAS No.:

1415456-99-3

Grade:

Pharmaceutical Grade

Content:

99%

Port:

SHENZHEN

Packaging:

5mg *10 vials

Price valid (until):

2026-02-27

Company Type:
Trader
Location:
China
Qualification:
Main Products:

GLP-1,Tirzepatide,Retatrutide,Semaglutide,Peptide

  • Product Description

  • Seller Information

  • Inquiry History

  • Description


      Our Company  


    Sales Manager: Sootung

    Email: sootung57@gmail.com

    Whatsapp: +86 134 1022 6528

    We are a comprehensive chemical enterprise integrating manufacturing, processing, and export, specializing in pharmaceutical intermediates and a wide range of industrial chemicals.

    Since our establishment, we have consistently upheld the principles of integrity, strict quality control, and customer-oriented service, earning strong recognition and long-term trust from customers worldwide through stable product quality and professional support.

    We have built a highly experienced international sales team capable of delivering full product solutions and providing efficient, one-stop professional services to global clients.

    With synthetic biology platform technology at our core, the company continuously advances innovative R&D, focusing on the development and production of recombinant therapeutic peptides and proteins.
    Our product portfolio includes:

    • Innovative drugs and APIs

    • Pharmaceutical and green synthetic industrial enzymes

    • Functional peptides and protein products

    Currently, multiple biosynthetic peptide products have been successfully industrialized, and we have established long-term partnerships with several well-known pharmaceutical companies worldwide, supported by continuous commercial orders.


    FAQ

    1. How to place an order?

    Please leave us a message with the product name and quantity you require. We will calculate the price and provide you with a formal quotation promptly.

    2. What is the delivery time and shipping method?

    After payment is confirmed, we will ship your order via USPS, FedEx, DHL, or UPS.
    The estimated delivery time is 5–15 business days, depending on the destination.

    3. How should peptides be stored after receipt?

    • Lyophilized peptides: Can be vacuum-packed and transported at room temperature

    • Peptides in solution: Should be stored refrigerated at 2°C–8°C

    • For long-term storage: Lyophilized peptides should be kept in a sealed container with desiccant and stored at -20°C or -80°C to minimize degradation

    4. What payment methods are accepted?

    We accept the following payment methods:
    PayPal, Bank Transfer, XTransfer, and Bitcoin (BTC)

    Items Specifications
    Cagrilintide
    5mg *10 vials




    ECHEMI Editorial Reference
    Cagrilintide is an amylin-analog, now being developed in combination with the GLP-1 agonist semaglutide to achieve sustained weight loss in persons with overweight and obesity. This drug is an investigational therapy that reduced body weight in a phase 2 trial when administered as monotherapy in participants without diabetes and with a BMI of at least 30 kg/m2 or at least 27 kg/m2 with hypertension or dyslipidaemia[1-2].

    Basic Info
    Product Name:

    Cagrilintide

    Other Name:

    Cagrilintide;Cargliptin;Caglitide;Cagrilintide acetate;Cagrilintide peptide;Cagrilintide 5mg 10mg 15mg;Cagrilintide(Acetate form);Kagliptin

    CAS No.:

    1415456-99-3

    Molecular Weight:

    0

    EC Number:

    206-141-6

    Color/Form:

    White to off-white

    Categories:

    Other Chemical Drugs

    Research
    Class:

    Amylin receptor (AMYR) / calcitonin receptor (CTR) agonist (long-acting amylin analog)

    Status:

    Investigational — Phase 3 (REDEFINE program, CagriSema combination)

    Mechanism:

    A novel long-acting, acylated amylin (islet amyloid polypeptide, IAPP) analog consisting of 38 amino acids. Cagrilintide activates the amylin receptor (AMYR) and calcitonin receptor (CTR), reducing food intake, delaying gastric emptying, and promoting satiety. Being developed as monotherapy and in fixed-dose combination with semaglutide (CagriSema) for obesity. Administered once weekly.

    Activity note:

    Cagrilintide is a non-selective AMYR/CTR agonist. Specific EC50 values not publicly available; functional potency is comparable to native amylin at AMYR.

    Source:

    MCE: Cagrilintide (CAS 1415456-99-3); Novo Nordisk REDEFINE program.

    Clinical Development:

    NCT05249895; NCT05249882

    References
    PubChem:

    PubChem

    Disclaimer:

    Cagrilintide is NOT FDA-approved or EMA-approved. It is in Phase 3 clinical trials (REDEFINE program). This listing is for industrial and laboratory research use only. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    GLP-1,Tirzepatide,Retatrutide,Semaglutide,Peptide

    Location:

    No. 80, Lane 280, Xiujing Road, Zhujing Town, Jinshan District, Shanghai, China (South Wing Economic Zone)

    Year of Establishment:

    2025

  • Inquiry History
    59 Inquiries
    Country Product Purchase Quantity Date Posted
    United Kingdom

    Cagrilintide

    10 MG Jul 31, 2026
    France

    Cagrilintide

    10 MG May 22, 2026
    Australia

    Cagrilintide

    4 MT Mar 9, 2026
    United States

    Cagrilintide

    15 MG Feb 25, 2026
    United States

    Cagrilintide

    10 PCS Dec 27, 2025
    United States

    Cagrilintide

    2 MT Dec 21, 2025
    United States

    Cagrilintide

    100 MG Oct 28, 2025
    United States

    cagrilintide

    2 MT Aug 8, 2025
    Philippines

    Retatrutide

    5 MG Aug 5, 2025
    China

    Cagrilintide

    100 G May 6, 2025
    United States

    cagrilintide

    5 MG Feb 18, 2025
    United States

    Cagrilintide

    3 MT Feb 7, 2025
    United States

    Cagrilintide

    100  Nov 12, 2024
    United States

    Cagrillintide Lyophilized powder

    100 MG Jul 4, 2024
    United States

    Cagrillintide Lyophilized powder

    1000 MG Apr 20, 2024
    United States

    Cagrlintide

    1 MT Jul 31, 2026
    United Kingdom

    cagrilintrude

    20 MG Jul 21, 2026
    United States

    Cagrilintide

    1 KG Jul 17, 2026
    United States

    Cagrilintide

    30 MG May 26, 2026
    United Kingdom

    CAGRILLINTED

    10  May 3, 2026
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.